Numerous studies and research carried out have set a precedent for the development of new orphan drugs. Biopharmaceuticals, as the name implies, are biologically sourced.

Since they’re usually large molecule proteins and nucleic acids, developing them follows a strict process. Examples include recombinant proteins and monoclonal antibodies, such as those used in cancer treatments.